期刊文献+

青光眼常用药物不良反应及护理措施 被引量:4

下载PDF
导出
作者 刘鲁霞
出处 《西南国防医药》 CAS 2007年第1期87-88,共2页 Medical Journal of National Defending Forces in Southwest China
  • 相关文献

参考文献4

二级参考文献25

  • 1方敏,余敏斌.高眼压症认识新进展[J].国外医学(眼科学分册),2004,28(5):312-316. 被引量:22
  • 2葛坚.我国近五年青光眼临床与基础研究进展[J].中华眼科杂志,2005,41(8):710-716. 被引量:150
  • 3陆道炎 盛耀华 译.青光眼的基础和临床[M].上海:上海科学技术出版社,1998.186.
  • 4周文炳,主编.临床青光眼.北京:人民卫生出版社,1998.337-362.
  • 5Michaud JE,Friren B.Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:235-243.
  • 6Netland PA,Landry T,Sullivan EK,et al.Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:472-484.
  • 7Richard KP.A comparison of latanoprost,bimatoprost and travoprost in patients with elevated intraocular pressure:a 12-week,randomized,masked-evaluator multicenter study.Am J Ophthalmol,2004,137:387-388.
  • 8Leske MC,Heijl A,Hyman L,et al.Early manifest glaucoma trial:design and baseline data.Ophthalmology,1999,106:2144-2153.
  • 9Leske MC,Heijl A,Hussein M,et al.Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial.Arch Ophthalmol,2003,121:48-56.
  • 10Leskea MC,Heijl A,Hyman L,et al.Factors for progression and glaucoma treatment:the early manifest glaucoma trial.Curr Opin Ophthalmol,2004,15:102-106.

共引文献74

同被引文献18

  • 1石晶明,蒋幼芹,葛坚,刘磊,孙兴怀,陈晓明,余敏斌,孙丽,郭文毅,李茅.派立明与贝特舒联合用药对青光眼和高眼压症疗效的多中心研究[J].中国实用眼科杂志,2004,22(12):969-972. 被引量:6
  • 2余敏斌,李劲嵘.青光眼药物治疗的新概念[J].中华眼科杂志,2006,42(3):283-288. 被引量:52
  • 3王宁利,李树宁.青光眼药物使用中的误区[J].眼科,2006,15(2):85-88. 被引量:14
  • 4刘鲁霞,薛丹.视频终端综合征的护理干预[J].解放军护理杂志,2006,23(8):61-62. 被引量:15
  • 5Foster PJ,Johnson GJ. Glaucoma in China,. How big is problem? [J]. Br J Ophthalmol,2001,85 : 1277 - 1282.
  • 6Pfeiffer N. A comparison of the fixed combination of latanoprost and timolol with its individual components[J]. Graefes Arch Clin Exp Opht halmol, 2002,240 ( 11 ) : 899.
  • 7Fristrom B,Nilsson SE. Interaction of PhXA41 ,a new prostaglandin analogue, with pilocarpine: A study on patients with elevated int raocular pressure[J].Arch Ophthalmol, 1993,111 (5) : 665.
  • 8Kimal AM,Topalkara A,Guler C,et al. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure[J]. Int Ophthalmol, 1998,22(1) : 42.
  • 9Aung T,Chew PT,Oen FT,et al. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure[J]. Br J Ophthalmol,2002,86(1) :79.
  • 10Widengard I,Maepea O,Alm A, Effect of latanoprost and dipivefrin,alone or combined,on intraocular pressure and on blood- aqueous barrier permeability [J]. Br J Ophthalmol, 1998,82 ( 4 ) : 406.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部